|
⚲
|
| Keyboard |
| Martin Tami Tillotson
✚
|
|
|---|---|
| CIK # | 0001539494 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001539494] | |
| 4 | [0001539494] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Martin Tami Tillotson | |
| Supernus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2024-02-23 | Disposed to issuer | 1,250 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-02-23 | Tax withheld | 485 | $29.06 | 14,094 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-02-23 | Grant | 1,250 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-02-22 | Grant | 750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2024-02-22 | Disposed to issuer | 750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-02-22 | Tax withheld | 246 | $27.94 | 6,873 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-01-10 | Option exercise | 8,000 | $9.24 | 73,920 |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2024-01-10 | Option exercise | 8,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-01-10 | Sell | 8,000 | $27.91 | 223,280 |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2023-08-30 | Option exercise | 8,100 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-08-30 | Option exercise | 8,100 | $23.99 | 194,319 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-08-30 | Sell | 8,100 | $32.00 | 259,200 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-08-25 | Sell | 5,135 | $31.59 | 162,215 |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2023-02-23 | Grant | 5,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2023-02-23 | Grant | 20,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2023-02-22 | Disposed to issuer | 750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-02-22 | Grant | 750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-02-16 | Option exercise | 1,500 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Performance Share Unit · derivative
|
2023-02-16 | Option exercise | 1,500 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Performance Share Unit · derivative
|
2023-01-12 | Grant | 1,500 | $0.00 | |
| showing 20 of 43 most recent transactions | |||||